Worldwide: Life Sciences, Biotechnology & Nanotechnology

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

[Blog] EPO Technology Dashboard 2025 : Croissance Modérée Des Brevets Et Essor Des Technologies Numériques

An unexpected error has occurred on this page. The technical team has been notified and is working to resolve the issue. Users are encouraged to retry their request.

NG

Novagraaf Group

Court Of Appeal, April 27, 2026, Order On Provisional Measures, UPC_CoA_917/2025

Unlike proceedings on the merits, where the Statement of defence shall include a Counterclaim for revocation (R. 25.1 RoP) if there is an assertion that the patent alleged to be infringed is invalid...

BP

Bardehle Pagenberg

EU AI Act Omnibus: Provisional Deal Announced – Initial Reflections For Life Sciences Companies

The European Parliament and Council have reached a provisional agreement on reforms to the EU AI Act, introducing extended compliance deadlines and clarifications for high-risk AI systems.

Belgium Healthcare

AP

Arnold & Porter

European Health & Life Sciences Symposium 2026: Key Takeaways From Paris

At McDermott’s European Health & Life Sciences Symposium 2026, more than 350 leaders gathered in Paris from across the life sciences and healthcare ecosystem to discuss the trends that are defining the sector’s future.

France Healthcare

SR

McDermott Will & Schulte

L’actualité juridique numérique de la semaine – 5 mai 2026

France Technology

HA

Haas Avocats

UPC Court Of Appeal Lowers Threshold In Establishing Imminent Patent Infringement For Generic Launch

PC

Potter Clarkson

LD Brussels, April 14, 2026, Procedural Order, UPC_CFI_1357/2025; UPC_CFI_629/2025

BP

Bardehle Pagenberg

Life Sciences And Healthcare M&A 2025: A Year In Review

Ireland Healthcare

AC

Arthur Cox

Guidelines On Malta’s Tax Treatment For Highly Skilled Individuals

PS

Papilio Services Limited

EU Pharma Package: Global (Orphan) Marketing Authorization Compromise Proposal

European Union Healthcare

CM

Crowell & Moring LLP

EU General Court Bars Patient Association From Challenging Medicine Authorisation Refusal

European Union Healthcare

A

Altius

Getting Ready For The EU Pharma Package Part 3: Accelerating Drug Development And Authorization

European Union Healthcare

AO

A&O Shearman

Le nouveau décret « hébergeurs » s’aligne sur le référentiel de certification s’agissant du lieu d’hébergement

France Healthcare

DA

Delsol Avocats

Despite EU Harmonisation, Member States May Impose Authorisation Requirements On Pharmacy-prepared Medicines, Rules EU Court Of Justice

Belgium Healthcare

A

Altius

Cryptocurrency Scam: What To Do And How To Recover Funds (2026)

Italy Technology

BI

Boccadutri International Law Firm

AvdR Legalflix | Ruud Brunninkhuis | Loon Als Boedelschuld (Video)

Netherlands Insolvency

B

Buren

Video update: Directiva Europea de Transparencia Retributiva y su impacto en España

Spain Employment

KL

Herbert Smith Freehills Kramer LLP

Inside The AI Act: In Conversation With Dr. Laura Caroli (Podcast)

Ireland Technology

WF

William Fry

Are You Receiving An Inheritance When Living In Spain?

Spain Wealth Mgt

SI

Spectrum IFA Group

The EU Pharma Package: The Transferable Exclusivity Voucher Compromise Proposal

Addressing antimicrobial resistance (AMR) is one of the key objectives of the EU’s legislative reform. However, the development pipeline for new effective antimicrobials is obstructed, primarily due to a profound market failure: the low commercial value of the antimicrobial medicinal product market (costly development versus naturally limited market). In short, the market alone cannot deliver the solutions urgently needed to address AMR.

European Union Healthcare

CM

Crowell & Moring LLP

CJEU Rules On GDPR Access Rights And Abuse Of Rights: What The Brillen Rottler Judgment Means For Life Sciences Companies

On 19 March 2026, the Court of Justice of the European Union (CJEU or Court) issued its judgment in Case C-526/24, Brillen Rottler GmbH & Co. KG v TC.

Belgium Healthcare

AP

Arnold & Porter

Pricing And Reimbursement Of Medicines In Ireland: New Framework Agreement 2026-2029 Published

Following the announcement in January that agreement had been reached, the full text of the Framework Agreement on the Supply and Pricing of Medicines ("FASPM")...

Ireland Healthcare

AC

Arthur Cox

Getting Ready For The EU Pharma Package Part 2: Stricter Rules On Environmental Risk Assessment – Everything You Need To Know

After the Council and the European Parliament have reached an agreement in the trilogue negotiations on the so-called Pharma Package in December 2025...

European Union Healthcare

AO

A&O Shearman

Non-compliance To The Interoperability, Ethics, And Security Standards May Be Penalized

France Healthcare

DA

Delsol Avocats

For Medical Devices, “Possible Use” Amounts To Infringement Only If The Use Is In Line With Medical Practice

AO

A&O Shearman

Belgium’s Healthcare Plans For 2026 – And Where Pharma Fits In

Belgium Healthcare

A

Altius

La non-conformité aux exigences des référentiels d'interopérabilité, d'éthique et de sécurité désormais sanctionnable

France Healthcare

DA

Delsol Avocats

The EU Pharma Package: Formal Adoption In Sight

European Union Healthcare

CM

Crowell & Moring LLP

The CNIL And The French National Authority For Health Join Forces To Support Digital Health Stakeholders

France Healthcare

DA

Delsol Avocats

La CNIL et la HAS s’associent pour accompagner les acteurs du numérique en santé

France Technology

DA

Delsol Avocats

Getting Ready For The EU Pharma Package: Key Changes To Regulatory Exclusivities, Orphan Medicinal Products And The “Bolar” Exemption Provisions

European Union Healthcare

AO

A&O Shearman

Movement On The Pharma Package: Formal Adoption Within Reach

Ireland Healthcare

AC

Arthur Cox

Greece’s New Ministerial Decision On Clinical Trial Contracts: Standardization, Timelines And E-signatures

Greece Healthcare

BL

Bernitsas

La CNIL et la HAS s’associent pour accompagner les acteurs du numérique en santé

La CNIL et la Haute Autorité de santé (« HAS ») ont signé le 10 mars 2026 une convention de partenariat destinée à renforcer...

France Technology

DA

Delsol Avocats

Getting Ready For The EU Pharma Package: Key Changes To Regulatory Exclusivities, Orphan Medicinal Products And The “Bolar” Exemption Provisions

After the Council and the European Parliament have reached an agreement in the trilogue negotiations on the so-called Pharma Package in December 2025, the texts of the provisional agreement (comprising a new regulation and a new directive) have now been published.

European Union Healthcare

AO

A&O Shearman

Movement On The Pharma Package: Formal Adoption Within Reach

The political agreement reached on the revision of the EU pharmaceutical legislation garnered much attention in December 2025 (see our briefing – EU Pharma Package: Agreement reached).

Ireland Healthcare

AC

Arthur Cox

Greece’s New Ministerial Decision On Clinical Trial Contracts: Standardization, Timelines And E-signatures

Our Life Sciences & Healthcare Briefing analyses Greece’s new Ministerial Decision introducing a standardized contractual regime for clinical research, aligning Greek procedures with the EU Clinical Trials Regulation, MDR and IVDR.

Greece Healthcare

BL

Bernitsas

The EU Pharma Package Is Finally Here – Here's The Settled Position On Key Areas

European Union Healthcare

KL

Herbert Smith Freehills Kramer LLP

The CNIL's Economic Analysis Unit Unveils Its 2026–2028 Work Programme

In 2023, the CNIL established a dedicated service for the economic analysis of issues related to personal data, with the aim of strengthening its expertise and informing its decisions through impact assessments...

France Healthcare

DA

Delsol Avocats

UPC Structure – Local, Regional And Central Divisions And Court Of Appeal, Judges & Languages

The UPC has a Court of First Instance (divided into local, regional and central divisions) and a Court of Appeal (Luxembourg). Cases can commence in any one of these divisions according...

KL

Herbert Smith Freehills Kramer LLP

EU Critical Medicines Act: What Life Sciences Companies Need To Know

MEPs agreed the European Parliament's negotiating position on the planned EU Critical Medicines Act (EU CMA) this week (20 January 2026), clearing the way for trilogue negotiations.

Ireland Healthcare

MF

McCann Fitzgerald

EHDS Regulation: Secondary Use Of Electronic Health Data

As part of the EU's Data Strategy, the European Health Data Space Regulation is intended to bring about greater reuse of electronic health data for research, innovation and policy-making purposes.

Ireland Healthcare

MF

McCann Fitzgerald

AGCOM Adopts New Age Verification Mechanisms For Websites And VSPS Disseminating Adult Content

Italy Healthcare

GA

Global Advertising Lawyers Alliance (GALA)

The European Accessibility Act As Implemented In Italy: What's New For Online Pharmacies?

Italy Healthcare

GA

Global Advertising Lawyers Alliance (GALA)

The UPC's Emerging Approach To Injunctions: Patterns, Pitfalls, And Global Implications

SR

McDermott Will & Schulte

EU Agrees Landmark Reform Of Pharmaceutical Legislation

Ireland Healthcare

MF

McCann Fitzgerald

Turning Europe Into A Biotech Powerhouse: Commission Unveils Biotech Act And Regulatory Simplification For Devices

Ireland Healthcare

MF

McCann Fitzgerald

Charting Ireland's Life Sciences Strategy: Scope And Policy Priorities

Ireland Healthcare

MF

McCann Fitzgerald

Clinical Trials Reform: Ireland's Blueprint For Transforming The Clinical Trials Landscape

Ireland Healthcare

MF

McCann Fitzgerald

Advertising And Labelling Of Medicinal Products On Social Media

Ireland Healthcare

AC

Arthur Cox

EU Reaches Agreement On ‘Pharma Package’ Legislative Reforms

Ireland Anti-trust

M

Matheson

The New Product Liability Directive

Belgium Consumer

A

Altius

What's Another Year 2026 - Life Sciences

European Union Healthcare

AC

Arthur Cox

Preliminary Questions On Article 10b Of The Medicinal Products Directive: A Gamechanger For The Admission Of Combination Medicines To The European Market?

European Union Healthcare

LL

Loyens & Loeff

European Commission Proposes Biotech Act To Boost Health Biotechnology In The EU

Belgium Healthcare

CM

Crowell & Moring LLP

European Regulation: What Does Implementing Regulation (EU) 2025/1466 Mean For Pharmaceutical Companies?

European Union Healthcare

UA

UGGC Avocats

Evolving Product Liability And Safety Landscape: Recent And Upcoming Regulatory Developments

Ireland Consumer

AC

Arthur Cox

See more

Latest Videos

See more

What Regulatory Challenges Are Facing The Life Sciences Sector? (Video)

WF

William Fry

Webinar Video | Lunch & Learn: Life Sciences : Morceaux Choisis

A

Altius

Webinar Video | Life Sciences Session #2: Vaccine Liability: What If Vaccination Goes Wrong?

A

Altius

Launch Of Our Medical Device Publication (Video)

WF

William Fry

Understanding Sunshine Rules: How New Transparency Regulations In Europe Are Changing Relationships Between Industry And Health Care Professionals (Video)

HL

Hogan Lovells

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More